מטוג'קט 10 מ"ג /מ"ל

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

METHOTREXATE 10 MG/ML

Commercializzato da:

TZAMAL BIO-PHARMA LTD

Codice ATC:

L01BA01

Forma farmaceutica:

SOLUTION FOR INJECTION

Via di somministrazione:

S.C, I.V, I.M

Prodotto da:

MEDAC GESELLSCHAFT FUER KLIN.SPEZIAL.mbh

Gruppo terapeutico:

METHOTREXATE

Indicazioni terapeutiche:

Psoriasis:because of the high risk attending its use, Methotrexate is indicated only in the symptomatic control of severe recalcitrant, disabling psoriasis which is not adequately responsive to other forms of therapy, and only when the diagnosis has been established, as by biopsy and/or after dermatological consultation. Rheumatoid Arthritis: Methotrexate can be used in the treatment of selected adults with severe rheumatoid arthritis, only when the diagnosis has been well estabished according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy, including full dose NSAIDs and usually a trial of at least one or more disease-modifying antirheumatic drugs.

Data dell'autorizzazione:

2011-05-01